Latest AI and machine learning research in genetics for healthcare professionals.
Heterozygous mutations in KMT2B are associated with an early-onset, progressive, and often complex...
We investigate the fundamental limits of transformer-based foundation models, extending our analys...
The study of DNA charge dynamics is a highly interdisciplinary field that bridges physics, chemist...
To understand the complex relationship between histone mark activity and gene expression, recent adv...
Rates of transcription elongation vary within and across eukaryotic gene bodies. Here, we introduce ...
In infected individuals, viruses are present as a population consisting of dominant and minor varian...
Understanding how genes influence phenotype across species is a fundamental challenge in genetic e...
Alzheimer's Disease (AD) affects over 55 million people globally, yet the key genetic contributors...
MedSAM, a medical foundation model derived from the SAM architecture, has demonstrated notable suc...
Large Language Models (LLMs) demonstrate remarkable generalizability across diverse tasks, yet gen...
Alzheimer's disease is an irreversible central neurodegenerative disease, and early diagnosis of Alz...
Language Model Agents (LMAs) are increasingly treated as capable of autonomously navigating intera...
Functional MRI (fMRI) and single-cell transcriptomics are pivotal in Alzheimer's disease (AD) rese...
The exploration of cellular heterogeneity within the tumor microenvironment (TME) via single-cell ...
Canonical correlation analysis (CCA) is a widely used technique for estimating associations betwee...
Transcription factors are proteins that regulate the expression of genes by binding to specific ge...
Recent technological advances have introduced new high-throughput methods for studying host-virus ...
The ability of tumors to evolve and adapt by developing subclones in different genetic and epigene...
Evolution by natural selection occurs at its most basic through the change in frequencies of alleles...
The rise of single-cell sequencing technologies has revolutionized the exploration of drug resista...
Cancer of unknown primary (CUP) constitutes between 2% and 5% of human malignancies and is among the...